Patents by Inventor Yanping Liu
Yanping Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12685737Abstract: Provided are an altrenogest injection and a preparation method and use thereof. The altrenogest injection includes 0.1-35 g altrenogest, 0.01-70 mL of polyethylene glycol, and a balance of an alcohol solvent per 100 mL of the altrenogest injection. The altrenogest injection can effectively inhibit estrus of sows, synchronize the estrus cycle of sows, and is more convenient and efficient to use, and the dosage is more precisely controllable. A single injection can effectively inhibit the estrus of sows for 6 to 12 days, which significantly reduces the labor costs for large-scale farms.Type: GrantFiled: August 16, 2021Date of Patent: July 21, 2026Assignee: NINGBO SANSHENG BIOLOGICAL TECHNOLOGY CO., LTDInventors: Xingchang Zheng, Sichao Zhou, Huanting Wu, Yuqiao Li, Yanping Liu, Guowei Yu, Xiaohong Li, Zhenzhen Yao, Jiani Shu, Mengyu Shao, Cencong Qi, Shiqiao Weng, Liming Zhou
-
Patent number: 12603185Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for generating a heterogenous network and determining diffusion weights of scientific evidence in the heterogenous network. The computer obtains clinical data associated with a clinical network of healthcare providers and scientific data associated with a scientific network of scientists. The computer generates a first graph network representing the clinical network and a second graph network representing the scientific network. The computer identifies a first set of target nodes in the first graph network representing clinical leaders, and a second set of target nodes in the second graph network representing scientific leaders. The computer predicts links connecting the first graph network to the second graph network and generates a heterogenous network with nodes from the first graph network and from the second graph network, and the links connecting the first graph network to the second graph network.Type: GrantFiled: July 19, 2024Date of Patent: April 14, 2026Assignee: IQVIA INC.Inventors: Yanping Liu, Steve Eichert, Yong Cai, Vishwaraj Dilesh Doshi, Tong Wu, Emily Zhao
-
Patent number: 12560752Abstract: An induction-type panel lamp and a lighting system are provided. The induction-type panel lamp includes a fixing frame, a light source component, and a sensing element, wherein the fixing frame is provided with a through space, an accommodating groove, and a second guide hole, the second guide hole communicates with the accommodating groove, the light source component is accommodated in the through space, the sensing element includes a detecting portion and a conducting portion which are connected to each other, the conducting portion penetrates the second guide hole and extends into the accommodating groove, the conducting portion is electrically connected to the light source component, and the detecting portion is arranged outside the fixing frame.Type: GrantFiled: March 1, 2024Date of Patent: February 24, 2026Assignee: ZHEJIANG TWINSEL ELECTRONIC TECHNOLOGY CO., LTD.Inventors: Bin Zhu, Anjun Zhang, Xueren Zeng, Qian Xu, Yanping Liu, Ping Rao
-
Publication number: 20260021131Abstract: A mitoxantrone liposome and capecitabine are used in treating nasopharyngeal carcinoma, in particular recurrent and/or metastatic nasopharyngeal carcinoma. Nasopharyngeal carcinoma, in particular recurrent and/or metastatic nasopharyngeal carcinoma, can be treated by administering a therapeutically effective dose of the mitoxantrone liposome and capecitabine to a patient with nasopharyngeal carcinoma.Type: ApplicationFiled: August 28, 2023Publication date: January 22, 2026Inventors: Chunlei LI, Yanping LIU, Mengmeng LI, Wei HUANG, Yanling DU, Lijuan HE, Shixia WANG, Qi DONG, Dong WANG, Jianfei XUE
-
Patent number: 12509712Abstract: Disclosed is a silk gland recombinant expression vector of silkworm expressing human epidermal growth factor, a preparation method and use thereof. The recombinant expression vector is formed by fusing truncated silk fibroin light chain N-terminal domain, C-terminal domain, optimized human epidermal growth factor and silkworm nuclear polyhedrosis virus enhancer, and removes the redundant part of the extra domain of endogenous silk protein contained in the fusion protein to the maximum extent.Type: GrantFiled: February 23, 2022Date of Patent: December 30, 2025Assignee: SOUTHWEST UNIVERSITYInventors: Dingpei Long, Xian Cheng, Jianfeng Sun, Yanping Liu, Fangyin Dai, Zhonghuai Xiang
-
Patent number: 12512212Abstract: Methods and systems to identify collaborative communities of individuals from graphs of multiple types of relationships amongst the individuals, including to mine data related to multiple types of relationships amongst individuals, construct graphs to represent the respective types of relationships amongst individuals, and perform a multiplex graph convolutional network (MGCN) artificial intelligence machine learning (AIML) analysis across the multiple graphs to identify the collaborative communities. A mathematical representation of the graphs may be learned/tuned to optimize clustering of the individuals. Multiple parameters (inter-graph weights, consensus regularization function) may be jointly tuned based on a joint optimization function. The collaborative communities may be displayed such that relative positions of the individuals represent measures of influence exerted by the respective individuals within the respective collaborative communities.Type: GrantFiled: December 21, 2021Date of Patent: December 30, 2025Assignee: IQVIA Inc.Inventors: Yong Cai, Yanping Liu, Ruoxin Li, Emily Zhao, Yilian Yuan, William McClellan
-
Publication number: 20250305020Abstract: Disclosed is a silk gland recombinant expression vector of silkworm expressing human epidermal growth factor, a preparation method and use thereof. The recombinant expression vector is formed by fusing truncated silk fibroin light chain N-terminal domain, C-terminal domain, optimized human epidermal growth factor and silkworm nuclear polyhedrosis virus enhancer, and removes the redundant part of the extra domain of endogenous silk protein contained in the fusion protein to the maximum extent.Type: ApplicationFiled: February 23, 2022Publication date: October 2, 2025Inventors: Dingpei LONG, Xian CHENG, Jianfeng SUN, Yanping LIU, Fangyin DAI, Zhonghuai XIANG
-
Publication number: 20250151213Abstract: A rolling-up screen includes a roller holder, a roller, a screen, a driving assembly, and multiple groups of supporting protection pieces. The roller holder is connected to a ceiling by a frame, or supported by a frame. The roller is rotatably connected between two plates of the roller holder. The screen includes display units in multiple rows and connected with the roller by hanging steel wire. The screen can be wound around the roller after retracting, and suspended below the roller by the hanging steel wire after unfolding. The driving assembly is arranged on the roller holder and connected with the roller to drive the roller to rotate, so as to enable the screen to be retracted and wound on the roller or unfolded and hung below the roller. The supporting protection pieces are arranged on the back surfaces of the display units in each row.Type: ApplicationFiled: January 10, 2025Publication date: May 8, 2025Inventors: Ning WANG, Yanping Liu
-
Publication number: 20240411080Abstract: An induction-type panel lamp and a lighting system are provided. The induction-type panel lamp includes a fixing frame, a light source component, and a sensing element, wherein the fixing frame is provided with a through space, an accommodating groove, and a second guide hole, the second guide hole communicates with the accommodating groove, the light source component is accommodated in the through space, the sensing element includes a detecting portion and a conducting portion which are connected to each other, the conducting portion penetrates the second guide hole and extends into the accommodating groove, the conducting portion is electrically connected to the light source component, and the detecting portion is arranged outside the fixing frame.Type: ApplicationFiled: March 1, 2024Publication date: December 12, 2024Inventors: Bin ZHU, Anjun ZHANG, Xueren ZENG, Qian XU, Yanping LIU, Ping RAO
-
Publication number: 20240331878Abstract: A method includes receiving data and integrating the data into a computing system. The method also includes applying a machine learning system to identify patients from the integrated data to place in one or more communities that include consumer-related data and social determinants of health data. The method also includes combining path projection, aggregation, and embedding to establish one or more paths to connect the patients to the communities based on the consumer-related data and/or the social determinants of health data in the one or more communities. The method also includes training a machine learning system to identify a correct path among the one or more established paths to place the patients on to be connected to the one or more communities.Type: ApplicationFiled: March 31, 2023Publication date: October 3, 2024Inventors: Yong CAI, Yanping LIU, Ruoxin LI, Emily ZHAO, Yilian YUAN
-
Publication number: 20240269092Abstract: Mitoxantrone hydrochloride liposome can be used in the preparation of drugs for treating advanced solid tumors. A higher therapeutically effective amount of mitoxantrone hydrochloride liposome, for example 8-150 mg/m2, is administered to patients with the advanced solid tumors. Animal test results show that the mitoxantrone hydrochloride liposome can effectively inhibit the growth of various solid tumor transplantation tumors. Clinical research results show that the mitoxantrone hydrochloride liposome can effectively treat advanced solid tumors, and is safe and controllable.Type: ApplicationFiled: May 27, 2022Publication date: August 15, 2024Inventors: Chunlei LI, Yanping LIU, Yanhui LI, Xuefang XIA, Min LIANG, Caixia WANG, Chunna LI, Jingjing ZHANG, Shixia WANG, Hongwei MENG
-
Publication number: 20240216393Abstract: Provided are an altrenogest injection and a preparation method and use thereof. The altrenogest injection includes 0.1-35 g altrenogest, 0.01-70 mL of polyethylene glycol, and a balance of an alcohol solvent per 100 mL of the altrenogest injection. The altrenogest injection can effectively inhibit estrus of sows, synchronize the estrus cycle of sows, and is more convenient and efficient to use, and the dosage is more precisely controllable. A single injection can effectively inhibit the estrus of sows for 6 to 12 days, which significantly reduces the labor costs for large-scale farms.Type: ApplicationFiled: August 16, 2021Publication date: July 4, 2024Inventors: Xingchang ZHENG, Sichao ZHOU, Huanting WU, Yuqiao LI, Yanping LIU, Guowei YU, Xiaohong LI, Zhenzhen YAO, Jiani SHU, Mengyu SHAO, Cencong QI, Shiqiao WENG, Liming ZHOU
-
Patent number: 12018262Abstract: Provided is a method for producing washing enzyme having protease resistance. According to the method, the washing enzyme having resistance to protease is obtained by carrying out fusion expression on a gene of the washing enzyme with the gene of a protease inhibitory peptide, thereby facilitating maintaining the stability of various enzyme components in an enzyme-containing detergent, and improving the use effect of the detergent.Type: GrantFiled: October 28, 2019Date of Patent: June 25, 2024Assignee: QINGDAO VLAND BIOTECH GROUP CO., LTDInventors: Qing Zhang, Zhibing Chen, Yanping Liu, Yanjun Tian, Wei Xu, Yinan Guan, Yijun Huang, Jiahua Lyu
-
Publication number: 20240122875Abstract: Provided is a use of a mitoxantrone hydrochloride liposome in the preparation of a drug for treating urothelial cancer, breast cancer, and bone and soft tissue sarcoma. Further provided is a method for treating urothelial cancer, breast cancer, and bone and soft tissue sarcoma, and the method is to administer a therapeutically effective amount of mitoxantrone hydrochloride liposomes to a patient in need. The mitoxantrone hydrochloride liposome can effectively treat urothelial cancer, breast cancer, and bone and soft tissue sarcoma, and compared with common mitoxantrone hydrochloride injections, the mitoxantrone hydrochloride liposome has better therapeutic effect and fewer adverse reactions.Type: ApplicationFiled: April 15, 2022Publication date: April 18, 2024Applicant: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTDInventors: Chunlei LI, Yanping LIU, Min LIANG, Mengmeng LI, Tong LI, Hua YANG, Shixia WANG, Sensen YANG
-
Patent number: 11923074Abstract: Embodiments of the present disclosure provide a method for identifying those entities within a network that have the most influence on other entities within the network. A multi-relational network comprising links among a plurality of physicians is generated based on peer network data, wherein each link indicates a first physician that influences a second physician, and a weight of the influence. A decision by a treating physician of the plurality of physicians is decomposed, using a deep learning engine, into a magnitude of peer influence and a magnitude of control factor influence based on the multi-relational network and a plurality of control factors respectively. The magnitude of peer influence among one or more physicians in the multi-relational network is distributed among physicians in the multi-relational network based on the links each physician maintains with other physicians.Type: GrantFiled: February 12, 2021Date of Patent: March 5, 2024Assignee: IQVIA Inc.Inventors: Ruoxin Li, Yong Cai, John H. Eichert, Jr., Emily Zhao, Yilian Yuan, Yanping Liu, Steve Eichert, D. Bruce West, William McClellan
-
Publication number: 20240058280Abstract: The present application provides a use of mitoxantrone hydrochloride liposome in the preparation of a medicament for treating ovarian cancer, gastric cancer or head and neck squamous cell carcinoma, a method for treating ovarian cancer, gastric cancer or head and neck squamous cell carcinoma using a mitoxantrone hydrochloride liposome formulation, and a mitoxantrone hydrochloride liposome formulation for treating ovarian cancer, gastric cancer or head and neck squamous cell carcinoma.Type: ApplicationFiled: December 14, 2021Publication date: February 22, 2024Inventors: Chunlei LI, Yanping LIU, Caixia WANG, Yanling DU, Xiaoyan WANG, Xueying SHEN, Shixia WANG, Shanshan SUN
-
Publication number: 20230197255Abstract: Methods and systems to identify collaborative communities of individuals from graphs of multiple types of relationships amongst the individuals, including to mine data related to multiple types of relationships amongst individuals, construct graphs to represent the respective types of relationships amongst individuals, and perform a multiplex graph convolutional network (MGCN) artificial intelligence machine learning (AIML) analysis across the multiple graphs to identify the collaborative communities. A mathematical representation of the graphs may be learned/tuned to optimize clustering of the individuals. Multiple parameters (inter-graph weights, consensus regularization function) may be jointly tuned based on a joint optimization function. The collaborative communities may be displayed such that relative positions of the individuals represent measures of influence exerted by the respective individuals within the respective collaborative communities.Type: ApplicationFiled: December 21, 2021Publication date: June 22, 2023Inventors: Yong CAI, Yanping LIU, Ruoxin LI, Emily ZHAO, Yilian YUAN, William MCCLELLAN
-
Patent number: D1070205Type: GrantFiled: January 17, 2025Date of Patent: April 8, 2025Assignee: Guangdong Souncrise Technology Co., Ltd.Inventor: Yanping Liu
-
Patent number: D1072772Type: GrantFiled: June 12, 2023Date of Patent: April 29, 2025Assignee: ZHEJIANG TWINSEL ELECTRONIC TECHNOLOGY CO., LTD.Inventors: Shiqing Xia, Jianping Yan, Yanping Liu, Xueren Zeng
-
Patent number: D1108691Type: GrantFiled: November 16, 2022Date of Patent: January 6, 2026Assignee: ZHEJIANG TWINSEL ELECTRONIC TECHNOLOGY CO., LTD.Inventors: Shiqing Xia, Xueren Zeng, Qian Xu, Yanping Liu, Jianping Yan